Citigroup’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,900
Closed -$7.52M 5733
2024
Q1
$7.52M Buy
+43,900
New +$8.19M ﹤0.01% 1444
2021
Q1
Sell
-4,200
Closed -$1.07M 7136
2020
Q4
$1.07M Sell
4,200
-5,600
-57% -$1.39M ﹤0.01% 3474
2020
Q3
$2.32M Buy
9,800
+900
+10% +$190K ﹤0.01% 2519
2020
Q2
$1.73M Sell
8,900
-6,900
-44% -$1.32M ﹤0.01% 2986
2020
Q1
$2.62M Sell
15,800
-4,000
-20% -$731K ﹤0.01% 2231
2019
Q4
$3.39M Sell
19,800
-13,300
-40% -$2.22M ﹤0.01% 2396
2019
Q3
$5.46M Buy
33,100
+23,200
+234% +$3.26M ﹤0.01% 1866
2019
Q2
$1.18M Sell
9,900
-5,500
-36% -$564K ﹤0.01% 3425
2019
Q1
$1.46M Buy
15,400
+9,500
+161% +$814K ﹤0.01% 2994
2018
Q4
$468K Buy
5,900
+5,200
+743% +$440K ﹤0.01% 4190
2018
Q3
$74K Buy
+700
New +$65.5K ﹤0.01% 6188

Other funds holding PODD

Citigroup's PODD Position: Q1 2026 in Review

Citigroup reduced its Insulet (PODD) stake by 30% in Q1 2026, selling an estimated $7.23M and leaving 66,493 shares worth $14M. The position accounts for 0.01% of the portfolio, ranked #1270.

Citigroup first reported a position in PODD in Q2 2013 and has held it in 51 quarters since. The position peaked at $27.7M in Q3 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Citigroup held 66,493 shares of Insulet worth $14M as of Q1 2026.
  • Citigroup sold 28,759 Insulet shares in Q1 2026, an estimated $7.23M.
  • Insulet made up 0.01% of Citigroup's portfolio in Q1 2026, its #1270 holding.
  • Citigroup first reported a position in Insulet in Q2 2013 and has held it in 51 quarters since.
  • Citigroup's Insulet position peaked at $27.7M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.